LIXTE BIOTECHNOLOGY HOLDINGS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported Cash And Cash Equivalents At Carrying Value of $4.20 million for the year ending 2023.

  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. showed a decrease of -21.5% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
  • This data is from LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2024.
  • XBRL data for this metric is available from 2012 to 2023 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 12 years of available data (2012 to 2023), LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 154.0%.
  • Historical annual values: Fiscal year 2023: $4.20 million | Fiscal year 2022: $5.35 million | Fiscal year 2021: $4.82 million | Fiscal year 2020: $5.07 million | Fiscal year 2019: $2.60 million | Fiscal year 2018: $4.27 million | Fiscal year 2017: $1.31 million | Fiscal year 2016: $199.9 thousand | Fiscal year 2015: $25.3 thousand | Fiscal year 2014: $44.4 thousand | Fiscal year 2013: $475.0 thousand | Fiscal year 2012: $1.66 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: